Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Malignant Melanoma

Free Subscription 06.07.2026 1 Ann Surg Oncol 2 Anticancer Res 1 BMC Cancer 1 Br J Cancer 2 J Am Acad Dermatol 2 J Immunol 1 J Invest Dermatol 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Surg Oncol

1. DOUGHERTY KE, Peery GB, Saravanan A, Pham VP, et al
   ASO Visual Abstract: Implementing Paradigm-Shifting Clinical Trials: Real-World Outcomes of Neoadjuvant Versus Adjuvant Immune Checkpoint Inhibitors in Advanced Melanoma Patients.
   Ann Surg Oncol. 2026 Jul 3. doi: 10.1245/s10434-026-20119.
   PubMed        
   
   

   
   Anticancer Res

2. MAJEWSKA O, Kulig P, Markiewicz D, Brzewski P, et al
   Clinical Features of Malignant Melanoma of the Skin Versus Suspicious Benign Skin Lesions.
   Anticancer Res. 2026;46:4087-4098.
   PubMed         Abstract available
   
   
3. IKUSHIMA C, Nakamura K, Furuta K, Iwata E, et al
   Dacarbazine Resistance in Melanoma Is Driven by Cell Cycle Dysregulation Stemming from Altered Cyclin D1, GSK-3beta, and p21 Expression.
   Anticancer Res. 2026;46:3797-3804.
   PubMed         Abstract available
   
   

   
   BMC Cancer

4. SALHI I, Bannoura S, Abedaljawwad O, Salah Z, et al
   Cutaneous and mucosal melanoma among the Palestinian population: a retrospective clinicopathological study with comparative regional context.
   BMC Cancer. 2026 Jun 29. doi: 10.1186/s12885-026-16393.
   PubMed         Abstract available
   
   

   
   Br J Cancer

5. CAVILLON A, Borget I, Robert C, Chevret S, et al
   The concept of functional cure in advanced/metastatic melanoma treated with combined nivolumab and ipilimumab or nivolumab alone.
   Br J Cancer. 2026 Jul 3. doi: 10.1038/s41416-026-03528.
   PubMed         Abstract available
   
   

   
   J Am Acad Dermatol

6. GRANT-KELS JM
   JAAD Game Changers: "Association between dermatology follow-up and melanoma survival: A population-based cohort study".
   J Am Acad Dermatol. 2026 Jun 27:S0190-9622(26)02996.
   PubMed        
   
   
7. GRANT-KELS JM
   JAAD Game Changers: "Excision margins for melanoma in situ on the head and neck-A single-center 10-year retrospective review of treatment with Mohs micrographic surgery".
   J Am Acad Dermatol. 2026 Jun 27:S0190-9622(26)02997.
   PubMed        
   
   

   
   J Immunol

8. PAL P, Wahi P, Paul S, Meitei HT, et al
   Complement C3 deficiency increases the effector and cytotoxic functions of NK cells and suppresses tumor growth.
   J Immunol. 2026;215:vkag157.
   PubMed         Abstract available
   
   
9. MACY AM, Herrmann LM, Thornley EM, Adams AC, et al
   MHC class II on melanoma cells regulates the anti-tumor T cell response.
   J Immunol. 2026;215:vkag158.
   PubMed         Abstract available
   
   

   
   J Invest Dermatol

10. GHAHARI N, Zheng L, Kuppanda PM, Chandra SS, et al
    Charting a new melanoma risk factor: Satellite Naevus Prevalence in High-Risk and Population-Based Cohorts.
    J Invest Dermatol. 2026 Jun 29:S0022-202X(26)02660.
    PubMed        
    
    

    
    PLoS One

11. KAKHKI NR, Hegedus Z, Tovari J, Mirzahosseini A, et al
    Metabolic profiling of human melanoma cell lines with high and low metastatic capacity by 1H-NMR spectroscopy.
    PLoS One. 2026;21:e0352639.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Melanoma is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum